American Academy of Neurology Annual Meeting

Nipocalimab in Myasthenia Gravis and the Remaining Needs for Patients

May 06, 2021

Jeffrey Guptill, MD, MS, MHS, associate professor of neurology at neurologist at Duke University, detailed early positive results for nipocalimab in myasthenia gravis and the urgency to provide more treatment options for patients.